Mouse apotransferrin, the iron-free form of the plasma glycoprotein transferrin, plays a central role in maintaining systemic iron homeostasis. It binds ferric ions (Fe³⁺) with high affinity at two specific metal-binding sites, enabling the controlled transport of iron through circulation and delivery to cells via transferrin receptor–mediated uptake. This tightly regulated process supports essential cellular functions such as erythropoiesis and metabolic enzyme activity.
In addition to iron transport, apotransferrin contributes to innate immune defense by limiting the availability of free iron required for microbial growth. By sequestering iron in plasma, it helps restrict bacterial proliferation and supports host defense mechanisms. Alterations in transferrin levels or function can disrupt iron balance and contribute to anemia or abnormal iron accumulation in tissues. Because of its defined iron-binding properties and physiological relevance, mouse apotransferrin is widely used in research involving iron metabolism, cell culture supplementation, host–pathogen interactions, and studies of iron transport mechanisms.
In biotechnology, ultra-purified apotransferrin (<0.01% iron content, 1.25 μg/mg iron-binding capacity) serves as an essential cell culture supplement, facilitating iron uptake through transferrin receptor-mediated endocytosis while preventing oxidative stress. Recent applications exploit its targeting potential in nanoparticle drug delivery systems for cancer therapeutics and as an antimicrobial adjuvant to enhance antibiotic efficacy against Gram-negative pathogens. The protein's solubility (10 mg/ml in aqueous solutions) and stability under physiological conditions enable its use in diagnostic assays and bioreactor media for biopharmaceutical production.
Not a hazardous substance or mixture.
11 - Combustible Solids